KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Deferred Taxes (2016 - 2025)

Merck (MRK) has disclosed Deferred Taxes for 17 consecutive years, with -$825.0 million as the latest value for Q4 2025.

  • Quarterly Deferred Taxes fell 33.93% to -$825.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.7 billion through Dec 2025, down 33.79% year-over-year, with the annual reading at -$1.7 billion for FY2025, 33.79% down from the prior year.
  • Deferred Taxes for Q4 2025 was -$825.0 million at Merck, down from -$212.0 million in the prior quarter.
  • The five-year high for Deferred Taxes was $159.0 million in Q4 2021, with the low at -$931.0 million in Q4 2023.
  • Average Deferred Taxes over 5 years is -$310.0 million, with a median of -$292.0 million recorded in 2022.
  • The sharpest move saw Deferred Taxes surged 126.59% in 2021, then crashed 66000.0% in 2022.
  • Over 5 years, Deferred Taxes stood at $159.0 million in 2021, then crashed by 293.08% to -$307.0 million in 2022, then crashed by 203.26% to -$931.0 million in 2023, then surged by 33.83% to -$616.0 million in 2024, then crashed by 33.93% to -$825.0 million in 2025.
  • According to Business Quant data, Deferred Taxes over the past three periods came in at -$825.0 million, -$212.0 million, and -$448.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.